Recent developments in mesoporous polydopamine-derived nanoplatforms for cancer theranostics

Zhu, Menglu; Shi, Yi; Shan, Yifan; Guo, Junyan; Song, Xuelong; Wu, Yuhua; Wu, Miaolian; Lu, Yan; Chen, Wei; Xu, Xiaoling; Tang, Longguang

doi:10.1186/s12951-021-01131-9

Journal of Nanobiotechnology

Table 1 Polydopamine-modified mesoporous silica applied in tumor treatment

From: Recent developments in mesoporous polydopamine-derived nanoplatforms for cancer theranostics

Formulation	Drug	Cancer	Therapy	Imaging	Application	Refs.
Nanoparticles	USIONPs	4T1	PTT- RT	MRI, PA	Cancer theranostics	[15]
Nanoparticles	Cur/ Silver	HeLa, A549/TAX	Chemotherapy		Cancer therapy	[16]
Nanoparticles	DOX	A549, A549/MDR	Chemotherapy		Multidrug resistance therapy	[17]
Nanoparticles	DOX	Hela	Chemotherapy		Targeted therapy	[18]
Nanoparticles	DOX	HT-1376	Chemotherapy		Targeted therapy	[19]
Nanoparticles	CQ	HepG-2	PTT	PA	Cancer therapy	[20]
Nanoparticles	DOX	4T1	Chemo-photothermal therapy		Cancer therapy	[21]
Nanoparticles	DES	HeLa	Chemotherapy		Cancer therapy	[22]
Nanoparticles	DM1	SW480	Chemotherapy		Targeted therapy	[23]
Nanoparticles	DOX, QUR	HCT-8, HCT-8/TAX	Chemotherapy		Multidrug resistance therapy	[24]
Nanoparticles	DOX, ICG	4 T1, MCF-7	Chemo-photothermal therapy	MRI, PA	Cancer theranostics	[25]
Nanoparticles	DOX	HepG2	Chemo-photothermal therapy	PA	Cancer theranostics	[26]
Nanoparticles	PTX	4T1	Chemotherapy		Cancer therapy	[27]
Nanoparticles	DOX	HeLa	Chemo-photothermal therapy		Targeted therapy	[28]
Nanoparticles	PFH/ICG	MCF-7	PTT/PDT	US/NIRF	Cancer theranostics	[29]
Nanoparticles	DOX	MHCC97L, MHCC97H	Chemo-photothermal therapy		Cancer therapy	[30]
Nanoparticles	DOX	MDA-MB-231	Chemo- photothermal therapy		Cancer therapy	[31]
Nanoparticles	DOX, PFP	MDA-MB-231	Chemo- photothermal therapy	US	Cancer theranostics	[32]
Nanoparticles	DOX	MCF-7	Chemotherapy	US	Targeted therapy	[33]
Nanoparticles	ABC, DOX, ICG	CT26	Chemo-photothermal therapy		Cancer therapy	[34]
Nanoparticles	CX-5461	HeLa			Targeted therapy	[35]
Nanoparticles	DOX	HepG2	Chemo-photothermal therapy/ Starvation therapy/Oxidative therapy		Targeted therapy	[36]
Nanoparticles	anti-miR-155	SW480	Gene therapy		Targeted therapy	[37]
Nanoparticles	TMZ	C6			Targeted therapy	[38]
Nanoparticles	PFH	4T1	PTT	PA/US/CT	Cancer theranostics	[39]
Nanoparticles	DOX	HeLa	Chemo-photothermal therapy		Cancer therapy	[40]
Nanoparticles	DOX, CUR	MCF-7/ADR	Chemotherapy		Multidrug resistance therapy	[41]
Nanoparticles	DOX	HeLa	Chemo-photothermal therapy		Targeted therapy	[42]
Nanoparticles	Cisplatin	HeLa	PTT		Cancer therapy	[43]
Nanoparticles	DOX,	HepG2			Cancer therapy	[44]
Nanoparticles	DOX, ICG, ABC	CT26	PTT-PDT- Chemotherapy		Targeted therapy	[45]
Nanoparticles	Gardiquimod	B16-F10	Photothermal-immunotherapy		Immunotherapy	[46]

Back to article page

ISSN: 1477-3155

Contact us

Submission enquiries: journalsubmissions@springernature.com